RPL38 and lymphoma: Furthermore, the oncogenic potential of c-MYC was strongly impaired by ribosomal protein haploinsufficiency genetic backgrounds, with the onset of lymphomas being dramatically delayed Eμ-Myc;L24+/− and Eμ-Myc;L38+/− mice compared to Eμ-Myc [40].